India's Vivo Bio Tech gains after getting 107.5 mln-rupee contract

Vivo Bio Tech

20/08/2025 08:33

** Shares of Vivo Bio Tech VIVO.BO rise 11.8% to 41.66 rupees

** Drug development and discovery services provider secures pre-clinical testing contract worth 107.5 mln rupees ($1.2 mln) for a novel molecule

** Contract includes toxicity studies across multiple endpoints, assessing genetic safety, environmental risk assessment, and analytical services

** Trading vols at 213,150 shares so far, over 4x the 30-day average

** Stock up ~12% YTD

($1 = 87.0800 Indian rupees)

 (Reporting by Vijay Malkar)

 ((VijayDattaram.Malkar@thomsonreuters.com;))